1. Home
  2. East Africa
  3. Kenya

Phase-two HIV/AIDS vaccine trials begin

Phase-two trials of Kenya's HIV/AIDS vaccine are underway, local newspaper the East African Standard reported on Thursday. Phase-one safety trials in the Kenya AIDS Vaccine Initiative (KAVI) were started two years ago. KAVI's lead researcher, Prof Job Bwayo, said while the initial phase was tested in two groups of 18 volunteers each, the second phase would involve between 100 and 1,000 volunteers. Bwayo said with the success of the initial phase, he was hopeful that phase-three trials - the results stage - would begin sooner than expected.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join